Pinehurst, North Carolina Clinical Trials
A listing of Pinehurst, North Carolina clinical trials actively recruiting patient volunteers.
Found (2) clinical trials
Patients are needed to participate in a clinical research study of Ovarian Endometrioid Adenocarcinoma, Deleterious BRCA2 Gene Mutation, Recurrent Ovarian Carcinoma, Ovarian Seromucinous Carcinoma, Fallopian Tube Transitional Cell Carcinoma, Recurrent Primary Peritoneal Carcinoma, Undifferentiated Ovarian Carcinoma, Ovarian Transitional Cell Carcinoma, Recurrent Fallopian Tube Carcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Ovarian Serous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Ovarian Clear Cell Adenocarcinoma, Undifferentiated Fallopian Tube Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Deleterious BRCA1 Gene Mutation to evaluate Paclitaxel, Olaparib, Pegylated Liposomal Doxorubicin Hydrochloride, Cediranib Maleate, Topotecan Hydrochloride
PRIMARY OBJECTIVES: I. To assess the efficacy and identify (in)active arm(s) of the combination of cediranib maleate (cediranib) and olaparib, cediranib alone, olaparib alone, and physician's choice standard of care chemotherapy, as measured by progression-free survival (PFS) in the setting of recurrent platinum-resistant or-refractory ovarian, primary peritoneal or fallopian tube ...
0.95 miles
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
PRIMARY OBJECTIVES: I. To evaluate whether adjuvant therapy with crizotinib will result in improved overall survival (OS) for patients with stage IB >= 4 cm, II and IIIA, ALK-positive non-small cell lung cancer (NSCLC) following surgical resection. SECONDARY OBJECTIVES: I. To evaluate and compare disease-free survival (DFS) associated with crizotinib. ...
2.25 miles
